{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:58:47Z","timestamp":1791475127680,"version":"4.3.4"},"reference-count":300,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Science is dynamic, and novel models to better understand experimental observations are very important for its advancement. In the context of cell biology, knowledge about how cells behave in response to extracellular stimuli, and how these processes are dysregulated in pathologic conditions, is one of the challenges of biological research nowadays. From a theoretical point of view, the discovery of the double-helix model of DNA structure led to the idea that most aspects of a cell\u2019s behavior could be understood by knowing the sequence and the rules regulating the expression of genes. A paradigm of this way of thinking is the theory of the \u201cselfish gene\u201d by Richard Dawkins. Indeed, this approach is being found to have several limitations, especially in the interpretations of complex pathologies, such as cancer, metabolic or neurodegenerative diseases. For this reason, a paradigm shift should be considered to provide a better modeling of the biological processes that control cellular behavior and physiology. In particular, a central role should be given to metabolism as a relay between the environment and microenvironment and cell function, by driving epigenetic modifications. For these reasons, a new \u201cselfish cell\u201d model should be introduced, which could prove useful to better explain complex diseases and find more effective translational approaches.<\/jats:p>","DOI":"10.3390\/biology15191790","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:16:52Z","timestamp":1791472612000},"page":"1790","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The \u201cSelfish Cell\u201d: The Central Role of Metabolism in Relaying Environmental Stimuli and Controlling Cellular Function"],"prefix":"10.3390","volume":"15","author":[{"given":"Sabina","family":"Di Matteo","sequence":"first","affiliation":[{"name":"Departmental Faculty of Medicine, UniCamillus-Saint Camillus International University of Health and Medical Sciences, 00131 Rome, Italy"},{"name":"IRCCS San Camillo Hospital, 30126 Venice, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gnocchi","sequence":"additional","affiliation":[{"name":"Departmental Faculty of Medicine, UniCamillus-Saint Camillus International University of Health and Medical Sciences, 00131 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1152\/physiol.00017.2018","article-title":"Central Dogma or Central Debate?","volume":"33","author":"Noble","year":"2018","journal-title":"Physiology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1113\/jphysiol.2010.201384","article-title":"Neo-Darwinism, the modern synthesis and selfish genes: Are they of use in physiology?","volume":"589","author":"Noble","year":"2011","journal-title":"J. Physiol."},{"key":"ref_3","first-page":"3001","article-title":"Genes and causation","volume":"366","author":"Noble","year":"2008","journal-title":"Philos. Trans. A Math. Phys. Eng. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11692-025-09651-0","article-title":"How the Central Dogma and the Theory of Selfish Genes Misled Evolutionary and Medical Sciences in Understanding Multi-factorial Diseases","volume":"52","author":"Noble","year":"2025","journal-title":"Evol. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1113\/JP290199","article-title":"There are more things in heaven and Earth than we dream of in our physiology","volume":"604","author":"Noble","year":"2025","journal-title":"J. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1113\/JP287139","article-title":"The cardiac pacemakers: A paradigm of robustness in evolutionary biology","volume":"604","author":"Noble","year":"2025","journal-title":"J. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1172\/JCI126119","article-title":"Promises, promises, and precision medicine","volume":"129","author":"Joyner","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10654-018-0385-9","article-title":"Epidemiology in wonderland: Big Data and precision medicine","volume":"33","author":"Saracci","year":"2018","journal-title":"Eur. J. Epidemiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jamainternmed.2014.2368","article-title":"Genotype-guided vs clinical dosing of warfarin and its analogues: Meta-analysis of randomized clinical trials","volume":"174","author":"Stergiopoulos","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/heartjnl-2018-313108","article-title":"Reaching cardiovascular prevention guideline targets with a polypill-based approach: A meta-analysis of randomised clinical trials","volume":"105","author":"Selak","year":"2019","journal-title":"Heart"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jamaoncol.2018.1660","article-title":"Estimation of the Percentage of US Patients with Cancer Who Benefit from Genome-Driven Oncology","volume":"4","author":"Marquart","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamaoncol.2018.5099","article-title":"Is Precision Medicine an Oxymoron?","volume":"5","author":"Eckhardt","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pensotti, A., Bertolaso, M., and Bizzarri, M. (2023). Is Cancer Reversible? Rethinking Carcinogenesis Models-A New Epistemological Tool. Biomolecules, 13.","DOI":"10.3390\/biom13050733"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2014.03.004","article-title":"Coming full circle-from endless complexity to simplicity and back again","volume":"157","author":"Weinberg","year":"2014","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.adr0544","article-title":"Integrating exposomics into biomedicine","volume":"388","author":"Miller","year":"2025","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"NCD Countdown Collaborators (2025). Benchmarking progress in non-communicable diseases: A global analysis of cause-specific mortality from 2001 to 2019. Lancet, 406, 1255\u20131282.","DOI":"10.1016\/S0140-6736(25)01388-1"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1192\/bja.2020.82","article-title":"The Immunology of Stress and the Impact of Inflammation on the Brain and Behavior","volume":"27","author":"Ravi","year":"2021","journal-title":"BJPsych Adv."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1037\/0278-6133.21.6.531","article-title":"Chronic psychological stress and the regulation of pro-inflammatory cytokines: A glucocorticoid-resistance model","volume":"21","author":"Miller","year":"2002","journal-title":"Health Psychol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neubiorev.2009.12.012","article-title":"Inflammation as a psychophysiological biomarker in chronic psychosocial stress","volume":"35","author":"Hansel","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_20","first-page":"524","article-title":"The multifaceted impact of circadian disruption on cancer risk: A systematic review of insights and economic implications","volume":"5","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.1260825","article-title":"Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions","volume":"347","author":"Tomasetti","year":"2015","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature16166","article-title":"Substantial contribution of extrinsic risk factors to cancer development","volume":"529","author":"Wu","year":"2016","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.aaf9011","article-title":"Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention","volume":"355","author":"Tomasetti","year":"2017","journal-title":"Science"},{"key":"ref_24","first-page":"5296","article-title":"Cancers beget mutations versus mutations beget cancers","volume":"54","author":"Prehn","year":"1994","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Nurgali, K., Jagoe, R.T., and Abalo, R. (2018). Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00245"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13054-017-1678-1","article-title":"Intensive Care in Hematological and Oncological Patients (iCHOP) Collaborative Group. New drugs, new toxicities: Severe side effects of modern targeted and immunotherapy of cancer and their management","volume":"21","author":"Kroschinsky","year":"2017","journal-title":"Crit. Care"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.mcna.2017.06.003","article-title":"Long-Term and Latent Side Effects of Specific Cancer Types","volume":"101","author":"Gegechkori","year":"2017","journal-title":"Med. Clin. N. Am."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41586-026-10803-1","article-title":"Prior therapy defines mutation profiles in childhood cancer at relapse","volume":"657","author":"Layeghifard","year":"2026","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Cisneros, L.H., Vaske, C., and Bussey, K.J. (2022). Identification of a signature of evolutionarily conserved stress-induced mutagenesis in cancer. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.932763"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood-2014-08-594408","article-title":"AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress","volume":"125","author":"Sriskanthadevan","year":"2015","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Baker, S.G., Soto, A.M., Sonnenschein, C., Cappuccio, A., Potter, J.D., and Kramer, B.S. (2009). Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: A computer simulation of morphostats. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-89"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/bies.201100025","article-title":"The tissue organization field theory of cancer: A testable replacement for the somatic mutation theory","volume":"33","author":"Soto","year":"2011","journal-title":"BioEssays"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF02705155","article-title":"Emergentism as a default: Cancer as a problem of tissue organization","volume":"30","author":"Soto","year":"2005","journal-title":"J. Biosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pbiomolbio.2016.06.006","article-title":"The biological default state of cell proliferation with variation and motility, a fundamental principle for a theory of organisms","volume":"122","author":"Soto","year":"2016","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/1098-2744(200012)29:4<205::AID-MC1002>3.0.CO;2-W","article-title":"Somatic mutation theory of carcinogenesis: Why it should be dropped and replaced","volume":"29","author":"Sonnenschein","year":"2000","journal-title":"Mol. Carcinog."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"015001","DOI":"10.1088\/1478-3975\/8\/1\/015001","article-title":"Cancer tumors as Metazoa 1.0: Tapping genes of ancient ancestors","volume":"8","author":"Davies","year":"2011","journal-title":"Phys. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-4682-8-30","article-title":"Cancer as a dynamical phase transition","volume":"8","author":"Davies","year":"2011","journal-title":"Theor. Biol. Med. Model."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pbiomolbio.2021.08.002","article-title":"Reverting to single-cell biology: The predictions of the atavism theory of cancer","volume":"165","author":"Bussey","year":"2021","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1073\/pnas.1706990114","article-title":"Ancestral gene regulatory networks drive cancer","volume":"114","author":"Bussey","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg1319","article-title":"The evolutionary dynamics of eukaryotic gene order","volume":"5","author":"Hurst","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41586-026-10639-9","article-title":"Gene ancestries reveal diverse microbial associations during eukaryogenesis","volume":"656","author":"Bernabeu","year":"2026","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"18045","DOI":"10.1073\/pnas.0910345106","article-title":"An early productive ocean unfit for aerobics","volume":"106","author":"Lyons","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/382127a0","article-title":"Late Proterozoic rise in atmospheric oxygen concentration inferred from phylogenetic and sulphur-isotope studies","volume":"382","author":"Canfield","year":"1996","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"20140219","DOI":"10.1098\/rstb.2014.0219","article-title":"Cancer across the tree of life: Cooperation and cheating in multicellularity","volume":"370","author":"Aktipis","year":"2015","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e40947","DOI":"10.7554\/eLife.40947","article-title":"Somatic mutations in early metazoan genes disrupt regulatory links between unicellular and multicellular genes in cancer","volume":"8","author":"Trigos","year":"2019","journal-title":"eLife"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/bjc.2017.398","article-title":"How the evolution of multicellularity set the stage for cancer","volume":"118","author":"Trigos","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1073\/pnas.1617743114","article-title":"Altered interactions between unicellular and multicellular genes drive hallmarks of transformation in a diverse range of solid tumors","volume":"114","author":"Trigos","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13059-024-03247-1","article-title":"Disruption of metazoan gene regulatory networks in cancer alters the balance of co-expression between genes of unicellular and multicellular origins","volume":"25","author":"Trigos","year":"2024","journal-title":"Genome Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The Metabolism of Tumors in the Body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e2409509121","DOI":"10.1073\/pnas.2409509121","article-title":"The Warburg Effect is the result of faster ATP production by glycolysis than respiration","volume":"121","author":"Kukurugya","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Cantley","year":"2009","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer-Then and now, and beyond","volume":"189","author":"Hanahan","year":"2026","journal-title":"Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41568-026-00950-y","article-title":"Imaging the hallmarks of cancer","volume":"26","author":"Grimm","year":"2026","journal-title":"Nat. Rev. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.gpb.2022.03.002","article-title":"Cancer Is a Survival Process under Persistent Microenvironmental and Cellular Stresses","volume":"21","author":"Tan","year":"2023","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/jmcb\/mjy039","article-title":"Fenton reactions drive nucleotide and ATP syntheses in cancer","volume":"10","author":"Sun","year":"2018","journal-title":"J. Mol. Cell Biol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Harguindey, S., Reshkin, S.J., and Alfarouk, K.O. (2023). The Prime and Integral Cause of Cancer in the Post-Warburg Era. Cancers, 15.","DOI":"10.3390\/cancers15020540"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-cancerbio-050216-121919","article-title":"Stress-Induced Mutagenesis: Implications in Cancer and Drug Resistance","volume":"1","author":"Fitzgerald","year":"2017","journal-title":"Annu. Rev. Cancer Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"102699","DOI":"10.1016\/j.ebiom.2020.102699","article-title":"Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance","volume":"54","author":"Nwosu","year":"2020","journal-title":"eBioMedicine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/CritRevOncog.v18.i1-2.40","article-title":"On the origin of cancer metastasis","volume":"18","author":"Seyfried","year":"2013","journal-title":"Crit. Rev. Oncog."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/carcin\/bgt480","article-title":"Cancer as a metabolic disease: Implications for novel therapeutics","volume":"35","author":"Seyfried","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10549-012-2283-2","article-title":"Mitochondria organelle transplantation: Introduction of normal epithelial mitochondria into human cancer cells inhibits proliferation and increases drug sensitivity","volume":"136","author":"Elliott","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"13628","DOI":"10.18632\/oncotarget.3698","article-title":"Enhanced tumorigenicity by mitochondrial DNA mild mutations","volume":"6","author":"Vallejo","year":"2015","journal-title":"Oncotarget"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e2502483122","DOI":"10.1073\/pnas.2502483122","article-title":"Restoring mitochondrial quantity and quality to reverse the Warburg effect and drive neuroblastoma differentiation","volume":"122","author":"Jiang","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.gene.2005.03.027","article-title":"Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis","volume":"354","author":"Singh","year":"2005","journal-title":"Gene"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1126\/science.1223560","article-title":"Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation","volume":"337","author":"Nargund","year":"2012","journal-title":"Science"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Jazwinski, S.M., and Kriete, A. (2012). The yeast retrograde response as a model of intracellular signaling of mitochondrial dysfunction. Front. Physiol., 3.","DOI":"10.3389\/fphys.2012.00139"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-94-007-2561-4_4","article-title":"The retrograde response retrograde response and other pathways of interorganelle communication interorganelle communication in yeast replicative aging","volume":"57","author":"Jazwinski","year":"2012","journal-title":"Subcell. Biochem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1038\/onc.2013.467","article-title":"Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells","volume":"33","author":"Guha","year":"2014","journal-title":"Oncogene"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.mito.2013.08.007","article-title":"Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics","volume":"13","author":"Guha","year":"2013","journal-title":"Mitochondrion"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"584","DOI":"10.18632\/oncotarget.965","article-title":"Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the (V600E)BRAF oncogene","volume":"4","author":"Hall","year":"2013","journal-title":"Oncotarget"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.eplepsyres.2011.06.017","article-title":"Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?","volume":"100","author":"Seyfried","year":"2012","journal-title":"Epilepsy Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"189593","DOI":"10.1016\/j.bbcan.2026.189593","article-title":"Mitochondrial respiration supports cancer growth independent of OXPHOS","volume":"1881","author":"Chinopoulos","year":"2026","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1126\/science.124.3215.267","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Weinhouse","year":"1956","journal-title":"Science"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.chemphyslip.2013.10.012","article-title":"Cardiolipin-dependent formation of mitochondrial respiratory supercomplexes","volume":"179","author":"Mileykovskaya","year":"2014","journal-title":"Chem. Phys. Lipids"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"C1150","DOI":"10.1152\/ajpcell.00538.2024","article-title":"Dysfunctional mitochondrial bioenergetics sustains drug resistance in cancer cells","volume":"328","author":"Gnocchi","year":"2025","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ccell.2018.01.010","article-title":"Transcriptional Regulation of the Warburg Effect in Cancer by SIX1","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e2011342118","DOI":"10.1073\/pnas.2011342118","article-title":"The harsh microenvironment in early breast cancer selects for a Warburg phenotype","volume":"118","author":"Damaghi","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrm2146","article-title":"Metaplasia and transdifferentiation: From pure biology to the clinic","volume":"8","author":"Slack","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/gutjnl-2025-335793","article-title":"Hybrid identity and distinct methylation profiles of incomplete intestinal metaplasia in the stomach","volume":"75","author":"Kim","year":"2025","journal-title":"Gut"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12964-023-01253-7","article-title":"Epigenetic meets metabolism: Novel vulnerabilities to fight cancer","volume":"21","author":"Scumaci","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1016\/j.febslet.2015.05.016","article-title":"A brief review of nucleosome structure","volume":"589","author":"Cutter","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","article-title":"Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis","volume":"187","author":"Zong","year":"2024","journal-title":"Cell"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.trecan.2017.12.005","article-title":"Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates","volume":"4","author":"Ye","year":"2018","journal-title":"Trends Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"891","DOI":"10.20892\/j.issn.2095-3941.2023.0467","article-title":"The Warburg effect drives dedifferentiation through epigenetic reprogramming","volume":"20","author":"Jiang","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41419-020-2303-9","article-title":"Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e2302489120","DOI":"10.1073\/pnas.2302489120","article-title":"Serine starvation silences estrogen receptor signaling through histone hypoacetylation","volume":"120","author":"Li","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Sultana, H., Solomon, A.D., Wani, A.K., and Shukla, S.K. (2025). Epigenetic dysregulation in pancreatic cancer: Emerging biomarkers and clinical applications. Front. Epigenet. Epigenom., 3.","DOI":"10.3389\/freae.2025.1723159"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/jnci\/djm231","article-title":"Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts","volume":"99","author":"Venkateswaran","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1749-6632.1996.tb16235.x","article-title":"Insulin receptors in breast cancer","volume":"784","author":"Belfiore","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_93","first-page":"565","article-title":"Insulin receptor expression and clinical outcome in node-negative breast cancer","volume":"109","author":"Mathieu","year":"1997","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jnci\/djn415","article-title":"Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women","volume":"101","author":"Gunter","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10549-012-2339-3","article-title":"Obesity as a risk factor for triple-negative breast cancers: A systematic review and meta-analysis","volume":"137","author":"Pierobon","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13072-019-0290-9","article-title":"Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer","volume":"12","author":"Senapati","year":"2019","journal-title":"Epigenet. Chromatin"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"622","DOI":"10.4093\/dmj.2021.0131","article-title":"Hyperinsulinemia in Obesity, Inflammation, and Cancer","volume":"45","author":"Zhang","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00592-011-0361-2","article-title":"Insulin resistance\/hyperinsulinemia and cancer mortality: The Cremona study at the 15th year of follow-up","volume":"49","author":"Perseghin","year":"2012","journal-title":"Acta Diabetol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ijc.30729","article-title":"Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population-based observational study","volume":"141","author":"Tsujimoto","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"105887","DOI":"10.1016\/j.envint.2020.105887","article-title":"What is new in the exposome?","volume":"143","author":"Vineis","year":"2020","journal-title":"Environ. Int."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Godoy, L.D., Rossignoli, M.T., Delfino-Pereira, P., Garcia-Cairasco, N., and de Lima Umeoka, E.H. (2018). A Comprehensive Overview on Stress Neurobiology: Basic Concepts and Clinical Implications. Front. Behav. Neurosci., 12.","DOI":"10.3389\/fnbeh.2018.00127"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41574-022-00746-8","article-title":"The multiple roles of life stress in metabolic disorders","volume":"19","author":"Kivimaki","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e01960","DOI":"10.1002\/brb3.1960","article-title":"Molecular links between endocrine, nervous and immune system during chronic stress","volume":"11","author":"Zefferino","year":"2021","journal-title":"Brain Behav."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Asem, M.S., Buechler, S., Wates, R.B., Miller, D.L., and Stack, M.S. (2016). Wnt5a Signaling in Cancer. Cancers, 8.","DOI":"10.3390\/cancers8090079"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"9865","DOI":"10.2147\/OTT.S266649","article-title":"Structural and Functional Overview of TEAD4 in Cancer Biology","volume":"13","author":"Chen","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/21655979.2021.1882142","article-title":"The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum\/glucocorticoid regulated kinase 1 (SGK1)","volume":"12","author":"He","year":"2021","journal-title":"Bioengineered"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/bcr3189","article-title":"DNA damage as a result of psychological stress: Implications for breast cancer","volume":"14","author":"Flint","year":"2012","journal-title":"Breast Cancer Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1196\/annals.1352.026","article-title":"Transcription factor NF-kappaB: A sensor for smoke and stress signals","volume":"1056","author":"Ahn","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41574-022-00773-5","article-title":"Metabolic determinants of tumour initiation","volume":"19","author":"Brunner","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMcibr2035081","article-title":"Obesity, Immunity, and Cancer","volume":"384","author":"Rathmell","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1099\/00221287-44-2-149","article-title":"The Crabtree effect: A regulatory system in yeast","volume":"44","year":"1966","journal-title":"J. Gen. Microbiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.glt.2024.01.001","article-title":"Cancer as a global health crisis with deep evolutionary roots","volume":"6","author":"Klement","year":"2024","journal-title":"Glob. Transit."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"k599","DOI":"10.1136\/bmj.k599","article-title":"Ultra-processed foods and cancer","volume":"360","author":"Monge","year":"2018","journal-title":"BMJ"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"eabo1673","DOI":"10.1126\/sciadv.abo1673","article-title":"Diabetic hyperglycemia promotes primary tumor progression through glycation-induced tumor extracellular matrix stiffening","volume":"8","author":"Wang","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1470-2045(04)01597-9","article-title":"Stress, depression, the immune system, and cancer","volume":"5","author":"Reiche","year":"2004","journal-title":"Lancet Oncol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1158\/1078-0432.CCR-10-2441","article-title":"Dopamine blocks stress-mediated ovarian carcinoma growth","volume":"17","author":"Lu","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cncr.31594","article-title":"Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of beta-adrenergic and cyclooxygenase 2 signaling","volume":"125","author":"Ricon","year":"2019","journal-title":"Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbi.2018.05.014","article-title":"Perioperative inhibition of beta-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome","volume":"73","author":"Haldar","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.4988","article-title":"Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre-metastatic niche through activating beta-adrenergic signaling","volume":"244","author":"Chen","year":"2018","journal-title":"J. Pathol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jaad.2004.08.042","article-title":"Chronic stress accelerates ultraviolet-induced cutaneous carcinogenesis","volume":"51","author":"Parker","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2018.01.012","article-title":"A Mitochondrial Health Index Sensitive to Mood and Caregiving Stress","volume":"84","author":"Picard","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"E6614","DOI":"10.1073\/pnas.1515733112","article-title":"Mitochondrial functions modulate neuroendocrine, metabolic, inflammatory, and transcriptional responses to acute psychological stress","volume":"112","author":"Picard","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yfrne.2018.01.001","article-title":"An energetic view of stress: Focus on mitochondria","volume":"49","author":"Picard","year":"2018","journal-title":"Front. Neuroendocrinol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/PSY.0000000000000544","article-title":"Psychological Stress and Mitochondria: A Conceptual Framework","volume":"80","author":"Picard","year":"2018","journal-title":"Psychosom. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PSY.0000000000000545","article-title":"Psychological Stress and Mitochondria: A Systematic Review","volume":"80","author":"Picard","year":"2018","journal-title":"Psychosom. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"105346","DOI":"10.1016\/j.psyneuen.2021.105346","article-title":"Effects of early-life stress on peripheral and central mitochondria in male mice across ages","volume":"132","author":"Ruigrok","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41583-018-0026-z","article-title":"Generation of circadian rhythms in the suprachiasmatic nucleus","volume":"19","author":"Hastings","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-3391-4-2","article-title":"Neurotransmitters of the suprachiasmatic nuclei","volume":"4","author":"Reghunandanan","year":"2006","journal-title":"J. Circadian Rhythms"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1113\/jphysiol.2001.012743","article-title":"GABA-induced current and circadian regulation of chloride in neurones of the rat suprachiasmatic nucleus","volume":"537","author":"Wagner","year":"2001","journal-title":"J. Physiol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Decker, M.J., Rye, D.B., Lee, S.Y., and Strohl, K.P. (2010). Paradoxical sleep suppresses immediate early gene expression in the rodent suprachiasmatic nuclei. Front. Neurol., 1.","DOI":"10.3389\/fneur.2010.00122"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/sleep\/30.11.1484","article-title":"Circadian rhythm sleep disorders: Part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review","volume":"30","author":"Sack","year":"2007","journal-title":"Sleep"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/sleep\/30.11.1460","article-title":"Circadian rhythm sleep disorders: Part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review","volume":"30","author":"Sack","year":"2007","journal-title":"Sleep"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/biology4010104","article-title":"Lipids around the Clock: Focus on Circadian Rhythms and Lipid Metabolism","volume":"4","author":"Gnocchi","year":"2015","journal-title":"Biology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1152\/physrev.00016.2012","article-title":"Metabolism and the circadian clock converge","volume":"93","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature09702","article-title":"Circadian clocks in human red blood cells","volume":"469","author":"Reddy","year":"2011","journal-title":"Nature"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature09654","article-title":"Circadian rhythms persist without transcription in a eukaryote","volume":"469","author":"Dixon","year":"2011","journal-title":"Nature"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1152\/physiol.00034.2019","article-title":"Melatonin in Mitochondria: Mitigating Clear and Present Dangers","volume":"35","author":"Reiter","year":"2020","journal-title":"Physiology"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Lei, X., Xu, Z., Huang, L., Huang, Y., Tu, S., Xu, L., and Liu, D. (2023). The potential influence of melatonin on mitochondrial quality control: A review. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1332567"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Bao, Y., Miao, G., He, N., Bao, X., Shi, Z., Hu, C., Liu, X., Wang, B., and Sun, C. (2026). Melatonin as a Guardian of Mitochondria: Mechanisms and Therapeutic Potential in Neurodegenerative Diseases. Biology, 15.","DOI":"10.3390\/biology15020189"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Gnocchi, D., and Bruscalupi, G. (2017). Circadian Rhythms and Hormonal Homeostasis: Pathophysiological Implications. Biology, 6.","DOI":"10.3390\/biology6010010"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e2220102120","DOI":"10.1073\/pnas.2220102120","article-title":"NAMPT-dependent NAD(+) biosynthesis controls circadian metabolism in a tissue-specific manner","volume":"120","author":"Basse","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1126\/science.1171641","article-title":"Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis","volume":"324","author":"Ramsey","year":"2009","journal-title":"Science"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e71138","DOI":"10.1002\/cam4.71138","article-title":"Haoya Wang Et Al.: Circadian Rhythm Disruption Promotes Tumor Progression Through Upregulated Glycolysis","volume":"14","author":"Wang","year":"2025","journal-title":"Cancer Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"C533","DOI":"10.1152\/ajpcell.00305.2020","article-title":"Out of breath, out of time: Interactions between HIF and circadian rhythms","volume":"319","author":"Martinez","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00018-019-03438-1","article-title":"Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: A mechanistic hypothesis","volume":"77","author":"Reiter","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41420-025-02788-z","article-title":"Melatonin suppresses cancer cell proliferation, DNA repair and expression of the oncogene TRIP13","volume":"11","author":"Liu","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1038\/s41388-026-03941-3","article-title":"Functional deficiency of circadian regulator PER2 enhances breast cancer susceptibility and progression with immunosuppression","volume":"45","author":"Duan","year":"2026","journal-title":"Oncogene"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0167-5699(99)01520-0","article-title":"Tryptophan catabolism and T-cell tolerance: Immunosuppression by starvation?","volume":"20","author":"Mellor","year":"1999","journal-title":"Immunol. Today"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1084\/jem.189.9.1363","article-title":"Inhibition of T cell proliferation by macrophage tryptophan catabolism","volume":"189","author":"Munn","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ijc.10645","article-title":"Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection","volume":"101","author":"Friberg","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat. Med."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Wang, S., Wu, J., Shen, H., and Wang, J. (2020). The prognostic value of IDO expression in solid tumors: A systematic review and meta-analysis. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-06956-5"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/bs.ircmb.2017.07.004","article-title":"Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer","volume":"336","author":"Prendergast","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_156","first-page":"3072","article-title":"Indoleamine 2,3-dioxygenase in tumor induced tolerance","volume":"122","author":"Liu","year":"2009","journal-title":"Chin. Med. J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ni.2077","article-title":"Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells","volume":"12","author":"Pallotta","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.1073\/pnas.1014465107","article-title":"Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism","volume":"107","author":"Nguyen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1158\/1078-0432.CCR-15-0420","article-title":"Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy","volume":"21","author":"Zhai","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.4049\/jimmunol.178.11.7018","article-title":"Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance","volume":"178","author":"Turnquist","year":"2007","journal-title":"J. Immunol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12967-016-0916-7","article-title":"mTOR inhibitors effects on regulatory T cells and on dendritic cells","volume":"14","author":"Stallone","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.it.2016.08.009","article-title":"mTOR-Mediated Regulation of Dendritic Cell Differentiation and Function","volume":"37","author":"Sukhbaatar","year":"2016","journal-title":"Trends Immunol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.4049\/jimmunol.1103741","article-title":"Inhibition of mechanistic target of rapamycin promotes dendritic cell activation and enhances therapeutic autologous vaccination in mice","volume":"189","author":"Amiel","year":"2012","journal-title":"J. Immunol."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Snyder, J.P., and Amiel, E. (2018). Regulation of Dendritic Cell Immune Function and Metabolism by Cellular Nutrient Sensor Mammalian Target of Rapamycin (mTOR). Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.03145"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","article-title":"Indoleamine 2,3 dioxygenase and metabolic control of immune responses","volume":"34","author":"Munn","year":"2013","journal-title":"Trends Immunol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J. Immunol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"110797","DOI":"10.1016\/j.exger.2019.110797","article-title":"Kynurenine signaling through the aryl hydrocarbon receptor: Implications for aging and healthspan","volume":"130","author":"Kaiser","year":"2020","journal-title":"Exp. Gerontol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"e006728","DOI":"10.1136\/jitc-2023-006728","article-title":"Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2\/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes","volume":"11","author":"Solvay","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"12391","DOI":"10.1038\/s41598-023-39262-8","article-title":"The immunosuppressive activity of myeloid-derived suppressor cells in murine Paracoccidioidomycosis relies on Indoleamine 2,3-dioxygenase activity and Dectin-1 and TLRs signaling","volume":"13","author":"Kaminski","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.celrep.2015.08.077","article-title":"Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner","volume":"13","author":"Holmgaard","year":"2015","journal-title":"Cell Rep."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/15384047.2018.1450116","article-title":"Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer","volume":"19","author":"Li","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s12672-024-01480-5","article-title":"Unveiling the Immune effects of AHR in tumors: A decade of insights from bibliometric analysis (2010\u20132023)","volume":"15","author":"Xie","year":"2024","journal-title":"Discov. Oncol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/s41423-022-00943-5","article-title":"Aryl hydrocarbon receptor activation drives polymorphonuclear myeloid-derived suppressor cell response and efficiently attenuates experimental Sjogren\u2019s syndrome","volume":"19","author":"Wei","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1182\/blood-2013-01-480129","article-title":"Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment","volume":"122","author":"Mussai","year":"2013","journal-title":"Blood"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Ham, S., Jo, M.J., Song, K.H., and Choi, B.H. (2026). Amino Acid-Driven Mitochondrial Metabolic Rewiring Controls Antitumor Immunity. Cancers, 18.","DOI":"10.3390\/cancers18091474"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by L-arginine metabolism","volume":"5","author":"Bronte","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"2109865","DOI":"10.1155\/2018\/2109865","article-title":"The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma","volume":"2018","author":"You","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40170-022-00301-z","article-title":"Arginase-1 inhibition reduces migration ability and metastatic colonization of colon cancer cells","volume":"11","author":"Wang","year":"2023","journal-title":"Cancer Metab."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2014.12.030","article-title":"The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo","volume":"42","author":"Blagih","year":"2015","journal-title":"Immunity"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.4049\/jimmunol.1401558","article-title":"mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function","volume":"193","author":"Donnelly","year":"2014","journal-title":"J. Immunol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cmet.2018.07.008","article-title":"Sweet Killers: NK Cells Need Glycolysis to Kill Tumors","volume":"28","author":"Isaacson","year":"2018","journal-title":"Cell Metab."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cmet.2018.06.021","article-title":"Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression","volume":"28","author":"Cong","year":"2018","journal-title":"Cell Metab."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ni.3838","article-title":"Srebp-controlled glucose metabolism is essential for NK cell functional responses","volume":"18","author":"Assmann","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"e166031","DOI":"10.1172\/JCI166031","article-title":"Glycolysis drives STING signaling to facilitate dendritic cell antitumor function","volume":"133","author":"Hu","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ni.3313","article-title":"Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction","volume":"17","author":"Zhao","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41568-020-0273-y","article-title":"Metabolism of immune cells in cancer","volume":"20","author":"Leone","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","article-title":"Navigating metabolic pathways to enhance antitumour immunity and immunotherapy","volume":"16","author":"Li","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: Glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"e1521","DOI":"10.1002\/ctm2.1521","article-title":"Targeting one-carbon metabolism for cancer immunotherapy","volume":"14","author":"Ren","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1172\/JCI131859","article-title":"Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells","volume":"130","author":"Oh","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s12672-025-02358-w","article-title":"Serine metabolism in tumor progression and immunotherapy","volume":"16","author":"Huang","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Lyu, H., Bao, S., Cai, L., Wang, M., Liu, Y., Sun, Y., and Hu, X. (2025). The role and research progress of serine metabolism in tumor cells. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1509662"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1083\/jcb.201604085","article-title":"The importance of serine metabolism in cancer","volume":"214","author":"Mattaini","year":"2016","journal-title":"J. Cell Biol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cmet.2016.12.011","article-title":"Serine Is an Essential Metabolite for Effector T Cell Expansion","volume":"25","author":"Ma","year":"2017","journal-title":"Cell Metab."},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Su, P., Yang, Y., and Zheng, H. (2026). The \u201cserine code\u201d of metabolic reprogramming: Multidimensional roles of the serine synthesis pathway in tumors and novel breakthroughs for targeted therapy. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1779543"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: Effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J. Immunol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Terren, I., Orrantia, A., Vitalle, J., Zenarruzabeitia, O., and Borrego, F. (2019). NK Cell Metabolism and Tumor Microenvironment. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02278"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1158\/2326-6066.CIR-18-0481","article-title":"Lactate-Mediated Acidification of Tumor Microenvironment Induces Apoptosis of Liver-Resident NK Cells in Colorectal Liver Metastasis","volume":"7","author":"Harmon","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc.2017.77","article-title":"Tumour acidosis: From the passenger to the driver\u2019s seat","volume":"17","author":"Corbet","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell Metab."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cmet.2018.09.020","article-title":"TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy","volume":"29","author":"Li","year":"2019","journal-title":"Cell Metab."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41419-026-08589-1","article-title":"Lactylation stabilizes PD-L1 to promote tumor immune evasion and cell growth","volume":"17","author":"Liang","year":"2026","journal-title":"Cell Death Dis."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"148","DOI":"10.21037\/tcr-2025-aw-2533","article-title":"Targeting LRPPRC lactylation disrupts metabolic-immune crosstalk and restores antitumor immunity in hepatocellular carcinoma","volume":"15","author":"Li","year":"2026","journal-title":"Transl. Cancer Res."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Chen, L., Huang, L., Gu, Y., Cang, W., Sun, P., and Xiang, Y. (2022). Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911943"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41590-025-02178-8","article-title":"Targeting lactylation reinforces NK cell cytotoxicity within the tumor microenvironment","volume":"26","author":"Jin","year":"2025","journal-title":"Nat. Immunol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s40364-025-00849-0","article-title":"Lactate and lactylation: Molecular insights into histone and non-histone lactylation in tumor progression, tumor immune microenvironment, and therapeutic strategies","volume":"13","author":"Xiao","year":"2025","journal-title":"Biomark. Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41420-026-03063-5","article-title":"Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer","volume":"12","author":"Ielpo","year":"2026","journal-title":"Cell Death Discov."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","article-title":"Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma","volume":"57","author":"Ugolini","year":"2024","journal-title":"Immunity"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1136\/gutjnl-2024-334361","article-title":"Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer","volume":"74","author":"Yang","year":"2025","journal-title":"Gut"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat. Med."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-15-0036","article-title":"Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies","volume":"3","author":"Hossain","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41586-021-03235-6","article-title":"Lipid signalling enforces functional specialization of T(reg) cells in tumours","volume":"591","author":"Lim","year":"2021","journal-title":"Nature"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.cmet.2019.02.016","article-title":"Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression","volume":"29","author":"Goossens","year":"2019","journal-title":"Cell Metab."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"e20191920","DOI":"10.1084\/jem.20191920","article-title":"Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells","volume":"217","author":"Manzo","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol Induces CD8(+) T Cell Exhaustion in the Tumor Microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol. Med."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","article-title":"The adenosine pathway in immuno-oncology","volume":"17","author":"Allard","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s12672-025-04001-0","article-title":"Cancer immunotherapy by adenosinergic CD39 and CD73 as emerging immune checkpoints","volume":"16","author":"Yin","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40425-018-0360-8","article-title":"Targeting adenosine for cancer immunotherapy","volume":"6","author":"Leone","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"e004089","DOI":"10.1136\/jitc-2021-004089","article-title":"Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy","volume":"10","author":"Augustin","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1517\/13543784.2011.627853","article-title":"Adenosine receptor targeting in health and disease","volume":"20","author":"Gessi","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.2174\/1381612825666190716102037","article-title":"Adenosine Receptors as Novel Targets for the Treatment of Various Cancers","volume":"25","author":"Gorain","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Ohta, A. (2016). A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00109"},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Majumder, B., and Datta, S. (2025). Adenosine receptors on the immuno-oncology expressway: TIME, perspectives, and translation. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1676702"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"Kishton","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ni.2833","article-title":"TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation","volume":"15","author":"Everts","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","article-title":"Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation","volume":"115","author":"Krawczyk","year":"2010","journal-title":"Blood"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13023-018-0914-3","article-title":"Cost-effectiveness analysis of lumacaftor and ivacaftor combination for the treatment of patients with cystic fibrosis in the United States","volume":"13","author":"Sharma","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.acvd.2013.10.007","article-title":"PCSK9: From discovery to therapeutic applications","volume":"107","author":"Farnier","year":"2014","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40801-024-00430-5","article-title":"PCSK9 Inhibitors and Infection-Related Adverse Events: A Pharmacovigilance Study Using the World Health Organization VigiBase","volume":"11","author":"Park","year":"2024","journal-title":"Drugs Real World Outcomes"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40264-020-01021-3","article-title":"PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database","volume":"44","author":"Zinzi","year":"2021","journal-title":"Drug Saf."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1136\/heartjnl-2016-309298","article-title":"Marginal role for 53 common genetic variants in cardiovascular disease prediction","volume":"102","author":"Morris","year":"2016","journal-title":"Heart"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"e053617","DOI":"10.1136\/bmjopen-2021-053617","article-title":"Comprehensive non-invasive prenatal screening for pregnancies with elevated risks of genetic disorders: Protocol for a prospective, multicentre study","volume":"11","author":"Xu","year":"2021","journal-title":"BMJ Open"},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Wang, C., Hou, D., Wang, G., Wu, X., Zhou, Z., Yang, L., Liu, Y., and Wang, X. (2026). Progress, clinical application and challenges of non-invasive prenatal testing for monogenic diseases. Front. Pediatr., 14.","DOI":"10.3389\/fped.2026.1734842"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/msb4100163","article-title":"Human disease classification in the postgenomic era: A complex systems approach to human pathobiology","volume":"3","author":"Loscalzo","year":"2007","journal-title":"Mol. Syst. Biol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3892\/or.2024.8707","article-title":"The phenotypic reversion of cancer: Experimental evidences on cancer reversibility through epigenetic mechanisms (Review)","volume":"51","author":"Pensotti","year":"2024","journal-title":"Oncol. Rep."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Zhang, M., Zhang, Q., Huang, S., Lu, Y., and Peng, M. (2025). Impact of ketogenic diets on cancer patient outcomes: A systematic review and meta-analysis. Front. Nutr., 12.","DOI":"10.3389\/fnut.2025.1535921"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drup.2015.08.004","article-title":"Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach","volume":"23","author":"Taylor","year":"2015","journal-title":"Drug Resist. Updates"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2217\/14796694.1.6.779","article-title":"Tumor acidity, chemoresistance and proton pump inhibitors","volume":"1","author":"Fais","year":"2005","journal-title":"Future Oncol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ijc.25009","article-title":"pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity","volume":"127","author":"Canese","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Fais, S., and Marunaka, Y. (2020). The Acidic Microenvironment: Is It a Phenotype of All Cancers? A Focus on Multiple Myeloma and Some Analogies with Diabetes Mellitus. Cancers, 12.","DOI":"10.3390\/cancers12113226"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"102677","DOI":"10.1016\/j.tranon.2026.102677","article-title":"Five-year survival of patients with non-small cell lung cancer treated with alkalization therapy","volume":"65","author":"Kachi","year":"2026","journal-title":"Transl. Oncol."},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Suzuki, K., Kachi, S., Hamaguchi, R., Morikawa, H., and Wada, H. (2026). Association of alkalization therapy with long-term survival in stage IV or recurrent colorectal cancer: Interaction with RAS mutation status. Front. Oncol., 16.","DOI":"10.3389\/fonc.2026.1867616"},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Oluwatola, O., Bazargan, S., Irrera, P., Chang, D., Thomas, A., Blauvelt, J., Beatty, M., Hall, M., Whelan, C.J., and Estrella, V. (2026). Transdermal bicarbonate buffer therapy increases intratumoral pH and elicits antitumor responses in bladder cancer. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1706250"},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Scharping, N.E., and Delgoffe, G.M. (2016). Tumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor Immunity. Vaccines, 4.","DOI":"10.3390\/vaccines4040046"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/0115665240435650260516221100","article-title":"Immunometabolic Reprogramming: A New Frontier in Cancer Immunotherapy","volume":"26","author":"Mohammadi","year":"2026","journal-title":"Curr. Mol. Med."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","article-title":"Monocarboxylate transporters in cancer","volume":"33","author":"Payen","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","article-title":"The future of cancer immunotherapy: Microenvironment-targeting combinations","volume":"30","author":"Warner","year":"2020","journal-title":"Cell Res."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40364-023-00500-w","article-title":"Review immune response of targeting CD39 in cancer","volume":"11","author":"Liu","year":"2023","journal-title":"Biomark. Res."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12943-025-02460-1","article-title":"Immunometabolism: Crosstalk with tumor metabolism and implications for cancer immunotherapy","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1038\/s41388-026-03836-3","article-title":"Intratumoral bicarbonate functions as an adjuvant to potentiate PD-1 blockade in hepatocellular carcinoma","volume":"45","author":"Wang","year":"2026","journal-title":"Oncogene"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11427-016-0373-3","article-title":"Will cancer cells be defeated by sodium bicarbonate?","volume":"60","author":"Zhang","year":"2017","journal-title":"Sci. China Life Sci."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"e002057","DOI":"10.1136\/jitc-2020-002057","article-title":"Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma","volume":"9","author":"Zakharia","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Al-Zoubi, R.M., Elaarag, M., Al-Qudimat, A.R., Al-Hurani, E.A., Fares, Z.E., Farhan, A., Al-Zoubi, S.R., Khan, A., Agouni, A., and Shkoor, M. (2025). IDO and TDO inhibitors in cancer immunotherapy: Mechanisms, clinical development, and future directions. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1632446"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-021-01080-8","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy","volume":"14","author":"Tang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10637-023-01416-w","article-title":"Phase I\/II trial of BMS-986,205 and nivolumab as first line therapy in hepatocellular carcinoma","volume":"42","author":"Huynh","year":"2024","journal-title":"Investig. New Drugs"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1158\/1078-0432.CCR-18-2740","article-title":"Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors","volume":"25","author":"Jung","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): A phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment","volume":"5","author":"Steggerda","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"e000249","DOI":"10.1136\/bmjonc-2023-000249","article-title":"First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours","volume":"3","author":"Naing","year":"2024","journal-title":"BMJ Oncol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/imm.13871","article-title":"Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment","volume":"174","author":"Aden","year":"2025","journal-title":"Immunology"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"18741","DOI":"10.1038\/s41598-025-03446-1","article-title":"Metabolomic reprogramming of the tumor microenvironment by dual arginase inhibitor OATD-02 boosts anticancer immunity","volume":"15","author":"Grzybowski","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1158\/1535-7163.MCT-22-0721","article-title":"Arginase 1\/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy","volume":"22","author":"Borek","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-22-2263","article-title":"A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer","volume":"29","author":"Halford","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1158\/2159-8290.CD-19-0980","article-title":"Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer","volume":"10","author":"Fong","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1158\/1078-0432.CCR-25-3727","article-title":"The Randomized Phase 2 ARC-9 Study of Etrumadenant-Based Therapy vs Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer","volume":"32","author":"Cecchini","year":"2026","journal-title":"Clin. Cancer Res."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/1878-0261.13583","article-title":"Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS-010759","volume":"18","author":"Belaid","year":"2024","journal-title":"Mol. Oncol."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"e005719","DOI":"10.1136\/jitc-2022-005719","article-title":"Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression","volume":"11","author":"Finisguerra","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12079-021-00648-w","article-title":"Targeting of the tumor immune microenvironment by metformin","volume":"16","author":"Wu","year":"2022","journal-title":"J. Cell Commun. Signal."},{"key":"ref_287","doi-asserted-by":"crossref","unstructured":"Abdelmoneim, M., Aboalela, M.A., Naoe, Y., Matsumura, S., Eissa, I.R., Bustos-Villalobos, I., Sibal, P.A., Takido, Y., Kodera, Y., and Kasuya, H. (2023). The Impact of Metformin on Tumor-Infiltrated Immune Cells: Preclinical and Clinical Studies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713353"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.4049\/jimmunol.1901213","article-title":"Metformin Enhances the Antitumor Activity of CD8(+) T Lymphocytes via the AMPK-miR-107-Eomes-PD-1 Pathway","volume":"204","author":"Zhang","year":"2020","journal-title":"J. Immunol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","article-title":"Metabolic coordination of T cell quiescence and activation","volume":"20","author":"Chapman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1016\/j.scib.2025.08.037","article-title":"Global burden of non-communicable diseases attributable to behavioral factors","volume":"70","author":"Zhu","year":"2025","journal-title":"Sci. Bull."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41387-025-00405-7","article-title":"Global burden of 13 non-communicable diseases attributable to high fasting plasma glucose from the GBD 2021 study","volume":"15","author":"Zhou","year":"2025","journal-title":"Nutr. Diabetes"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/epi-2017-0045","article-title":"Epigenetics and noncommunicable diseases","volume":"9","author":"Sharp","year":"2017","journal-title":"Epigenomics"},{"key":"ref_294","first-page":"1193","article-title":"The most northerly practice in Canada","volume":"147","author":"Urquhart","year":"1992","journal-title":"Can. Med. Assoc. J."},{"key":"ref_295","first-page":"1335","article-title":"Blue Zones, an Analysis of Existing Evidence through a Scoping Review","volume":"17","author":"Teijeiro","year":"2025","journal-title":"Aging Dis."},{"key":"ref_296","doi-asserted-by":"crossref","unstructured":"Aliberti, S.M., Capunzo, M., Galimberti, D., Accardi, G., Aiello, A., Calabro, A., Caruso, C., and Candore, G. (2025). Ageing Trajectories: Exposome-Driven Pathobiological Mechanisms and Implications for Prevention from Blue Zones and Italian Longevity Hotspots Such as Cilento and Sicilian Mountain Villages. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26104796"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF02185763","article-title":"The heritability of human longevity: A population-based study of 2872 Danish twin pairs born 1870\u20131900","volume":"97","author":"Herskind","year":"1996","journal-title":"Hum. Genet."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/S2468-2667(24)00156-7","article-title":"Differences in cancer rates among adults born between 1920 and 1990 in the USA: An analysis of population-based cancer registry data","volume":"9","author":"Sung","year":"2024","journal-title":"Lancet Public Health"},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.7326\/M21-3324","article-title":"Vitamin D Deficiency Increases Mortality Risk in the UK Biobank: A Nonlinear Mendelian Randomization Study","volume":"175","author":"Sutherland","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1126\/science.847460","article-title":"The need for a new medical model: A challenge for biomedicine","volume":"196","author":"Engel","year":"1977","journal-title":"Science"}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/19\/1790\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:32:03Z","timestamp":1791473523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/19\/1790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":300,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["biology15191790"],"URL":"https:\/\/doi.org\/10.3390\/biology15191790","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}